Source |
Alliance of Genome Resources |
Category | ID | Classification term | Gene | Evidence | Inferred from | Organism | Reference |
---|---|---|---|---|---|---|---|
Molecular Function | GO:0008047 | enzyme activator activity | APOA5 | IDA | Human | PMID:16806135 | |
Molecular Function | GO:0019899 | enzyme binding | APOA5 | IDA | Human | PMID:15178420 | |
Molecular Function | GO:0008201 | heparin binding | APOA5 | IDA | Human | PMID:15878877 | |
Molecular Function | GO:0008201 | heparin binding | APOA5 | IDA | Human | PMID:17326667 | |
Molecular Function | GO:0060229 | lipase activator activity | APOA5 | IMP | Human | PMID:15178420 | |
Molecular Function | GO:0035473 | lipase binding | APOA5 | IPI | UniProtKB:P06858 | Human | PMID:15178420 |
Molecular Function | GO:0008289 | lipid binding | APOA5 | IDA | Human | PMID:12810715 | |
Molecular Function | GO:0060230 | lipoprotein lipase activator activity | APOA5 | IDA | Human | PMID:18635818 | |
Molecular Function | GO:0070325 | lipoprotein particle receptor binding | APOA5 | IPI | UniProtKB:P98165 | Human | PMID:18635818 |
Molecular Function | GO:0070325 | lipoprotein particle receptor binding | APOA5 | IPI | UniProtKB:Q07954 | Human | PMID:18635818 |
Molecular Function | GO:0050750 | low-density lipoprotein particle receptor binding | APOA5 | IPI | UniProtKB:Q07954 | Human | PMID:17326667 |
Molecular Function | GO:0050750 | low-density lipoprotein particle receptor binding | APOA5 | IPI | UniProtKB:Q92673 | Human | PMID:17326667 |
Molecular Function | GO:0031210 | phosphatidylcholine binding | APOA5 | IDA | Human | PMID:16806135 | |
Molecular Function | GO:0005543 | phospholipid binding | APOA5 | IDA | Human | PMID:12810715 | |
Molecular Function | GO:0005515 | protein binding | APOA5 | IPI | UniProtKB:A0PK00 | Human | PMID:32296183 |
Molecular Function | GO:0005515 | protein binding | APOA5 | IPI | UniProtKB:O95070 | Human | PMID:32296183 |
Molecular Function | GO:0005515 | protein binding | APOA5 | IPI | UniProtKB:O95393 | Human | PMID:32296183 |
Molecular Function | GO:0005515 | protein binding | APOA5 | IPI | UniProtKB:P49638 | Human | PMID:32296183 |
Molecular Function | GO:0005515 | protein binding | APOA5 | IPI | UniProtKB:Q8NDC4 | Human | PMID:32296183 |
Molecular Function | GO:0005515 | protein binding | APOA5 | IPI | UniProtKB:Q96CM8 | Human | PMID:32296183 |
Molecular Function | GO:0005515 | protein binding | APOA5 | IPI | UniProtKB:Q96DZ9-2 | Human | PMID:32296183 |
Molecular Function | GO:0005515 | protein binding | APOA5 | IPI | UniProtKB:Q96HH6 | Human | PMID:32296183 |
Molecular Function | GO:0005515 | protein binding | APOA5 | IPI | UniProtKB:Q96MX0 | Human | PMID:32296183 |
Molecular Function | GO:0005515 | protein binding | APOA5 | IPI | UniProtKB:Q9BQE4 | Human | PMID:32296183 |
Molecular Function | GO:0005515 | protein binding | APOA5 | IPI | UniProtKB:Q9BTV4 | Human | PMID:32296183 |
Molecular Function | GO:0005515 | protein binding | APOA5 | IPI | UniProtKB:Q9HB07 | Human | PMID:32296183 |
Molecular Function | GO:0005515 | protein binding | APOA5 | IPI | UniProtKB:Q9NX76 | Human | PMID:32296183 |
Cellular Component | GO:0042627 | chylomicron | APOA5 | IDA | Human | PMID:15528295 | |
Cellular Component | GO:0005576 | extracellular region | APOA5 | IDA | Human | PMID:11577099 | |
Cellular Component | GO:0005615 | extracellular space | APOA5 | IDA | Human | PMID:18635818 | |
Cellular Component | GO:0005615 | extracellular space | APOA5 | IDA | Human | PMID:19121291 | |
Cellular Component | GO:0005615 | extracellular space | Apoa5 | IDA | Rat | PMID:19694729|RGD:2313326 | |
Cellular Component | GO:0034364 | high-density lipoprotein particle | APOA5 | IDA | Human | PMID:15528295 | |
Cellular Component | GO:0034361 | very-low-density lipoprotein particle | APOA5 | IDA | Human | PMID:15528295 | |
Biological Process | GO:0055090 | acylglycerol homeostasis | APOA5 | IDA | Human | PMID:11588264 | |
Biological Process | GO:0055090 | acylglycerol homeostasis | APOA5 | IMP | Human | PMID:15178420 | |
Biological Process | GO:0055090 | acylglycerol homeostasis | Apoa5 | IMP | Mouse | MGI:MGI:2151719|PMID:11588264 | |
Biological Process | GO:0031100 | animal organ regeneration | Apoa5 | IEP | Rat | PMID:11577099|RGD:70662 | |
Biological Process | GO:0042632 | cholesterol homeostasis | APOA5 | IDA | Human | PMID:19121291 | |
Biological Process | GO:0006869 | lipid transport | APOA5 | IDA | Human | PMID:15178420 | |
Biological Process | GO:0006869 | lipid transport | Apoa5 | IMP | Rat | PMID:11588264|RGD:631983 | |
Biological Process | GO:0045723 | positive regulation of fatty acid biosynthetic process | APOA5 | IDA | Human | PMID:18635818 | |
Biological Process | GO:0050996 | positive regulation of lipid catabolic process | APOA5 | IDA | Human | PMID:16806135 | |
Biological Process | GO:0051006 | positive regulation of lipoprotein lipase activity | APOA5 | IDA | Human | PMID:15178420 | |
Biological Process | GO:0051006 | positive regulation of lipoprotein lipase activity | APOA5 | IDA | Human | PMID:16806135 | |
Biological Process | GO:0051006 | positive regulation of lipoprotein lipase activity | APOA5 | IDA | Human | PMID:18635818 | |
Biological Process | GO:0010898 | positive regulation of triglyceride catabolic process | APOA5 | IDA | Human | PMID:18635818 | |
Biological Process | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling | APOA5 | IDA | Human | PMID:18635818 | |
Biological Process | GO:0009725 | response to hormone | Apoa5 | IEP | Rat | PMID:15941710|RGD:1601661 | |
Biological Process | GO:0042246 | tissue regeneration | APOA5 | IEP | Human | PMID:11577099 | |
Biological Process | GO:0019433 | triglyceride catabolic process | APOA5 | IMP | Human | PMID:15178420 | |
Biological Process | GO:0070328 | triglyceride homeostasis | APOA5 | IMP | Human | PMID:18635818 | |
Biological Process | GO:0070328 | triglyceride homeostasis | APOA5 | IDA | Human | PMID:19121291 | |
Biological Process | GO:0006641 | triglyceride metabolic process | APOA5 | IDA | Human | PMID:11588264 | |
Biological Process | GO:0006641 | triglyceride metabolic process | APOA5 | IMP | Human | PMID:12417525 | |
Biological Process | GO:0006641 | triglyceride metabolic process | APOA5 | IMP | Human | PMID:14729863 | |
Biological Process | GO:0006641 | triglyceride metabolic process | APOA5 | IMP | Human | PMID:17142127 | |
Biological Process | GO:0006641 | triglyceride metabolic process | Apoa5 | IMP | MGI:MGI:3609233 | Mouse | PMID:16166565 |
Biological Process | GO:0034370 | triglyceride-rich lipoprotein particle remodeling | Apoa5 | IMP | MGI:MGI:3609233 | Mouse | PMID:16166565 |
EXP Inferred from experiment |
IDA Inferred from direct assay |
IEP Inferred from expression pattern |
IGI Inferred from genetic interaction |
IMP Inferred from mutant phenotype |
IPI Inferred from physical interaction |
HTP Inferred from High Throughput Experiment |
HDA Inferred from High Throughput Direct Assay |
HMP Inferred from High Throughput Mutant Phenotype |
HGI Inferred from High Throughput Genetic Interaction |
HEP Inferred from High Throughput Expression Pattern |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/19/2024 MGI 6.24 |
|
|